Table 1.
Demographic Characteristics of Both OCD Patient Groups
| OCD patients’ 2-month follow-up (n = 113) | OCD patients’ 6-month follow up (n = 90) | ||
|---|---|---|---|
| Gender, male/female, n | 56/57 | 47/43 | |
| Age, range, mean | 8–18, 14.3 ± 3.2 | 9–18, 14.8, ± 3.2 (n = 17) | |
| Child and adolescence (n = 25) | 19–73, 33.8 ± 10.5 | 19–73, 35.6, 33.8 ± 9.6 (n = 73) | |
| Adults (n = 88) | |||
| Marital statusa (n) | Single (n = 13) | Single (n = 12) | |
| Married (n = 36) | Married (n = 34) | ||
| General employmentb | 68/84 (80%) | 51/69 (73%) | |
| Currently on leave due to pandemic | 45\84 (53%) | 39/69 (56%) | |
| OCD domains | Harm\aggressive | 15 (13%) | 12 (13%) |
| Sexual\religious | 16 (14%) | 15 (16%) | |
| Symmetry\ordering | 4 (3%) | 1(1%) | |
| Contamination, illness\washing | 46 (41%) | 36 (39%) | |
| Checking\repeating | 29 (26%) | 26 (29%) | |
| OCRD domains | Trichotillomania | 6 (5%) | 5(5%) |
| Body dysmorphic disorder | 2 (2%) | 2(2%) | |
| Skin picking | 7 (6%) | 5 (5%) | |
| Hoarding | 5(4%) | 4(4%) | |
| Medications | Escitalopram 20–40 mg | 27(24%) | 23(25%) |
| Fluoxetine 20–40 mg | 11(10%) | 8(9%) | |
| Fluoxetine 60–80 mg | 12(11%) | 7(8%) | |
| Fluvoxamine 200–500 mg | 11(10%) | 9(10%) | |
| Sertraline 150–200 mg | 19(16%) | 16(18%) | |
| Sertraline 250–500 mg | 33(29%) | 27(30%) | |
| Aripiprazole augmentation (2.5–5 mg) | 74(65%) | 63(70%) | |
| Aripiprazole augmentation (7.5–10 mg) | 6(5%) | 4(4%) |
Abbreviations: OCD, obsessive-compulsive disorder; OCRD, obsessive compulsive and related disorders.
aCalculated only for patients above the age of 27 (the average age of marriage in Israel).
bCalculated only for patients above the age of 21.